Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Interferon Alfa-2b for Melanoma With Early Lymph Node Metastasis
NCT00004196Phase 3Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Oct 1999
- Primary completion
- Oct 2004
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa-2b in melanoma, sponsored by University of Alabama at Birmingham. Started Oct 1999; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00004196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004196.